IPO Allotment Status: Meesho, Aequs & Vidya Wires IPO allotment finalised; how to check status online?

Ahead of listing, the unlisted shares of the company were trading with 24.19 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

Ahead of listing, the unlisted shares of the company were trading with 31.53 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

Ahead of listing, the unlisted shares of the company were trading with nearly 8 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has fallen from the 10.58 percent quoted by the site on December 4 (Day 2 of public bidding), but increased from the 5.77 percent quoted on the day the IPO closed for subscription (December 5).

• Step 1: Open the direct link to the registrar on this URL (https://ipostatus.kfintech.com/).
• Step 2: Select the IPO from the dropdown menu.
• Step 3: Investors can check the allotment status by filling in details like PAN, Application number or DP client ID.
• Step 4: Press the Submit button
• Step 5: The allotment status will be shown in the window

• Step 1: Open the direct link to the registrar on this URL (https://ipostatus.kfintech.com/).
• Step 2: Select the IPO from the dropdown menu.
• Step 3: Investors can check the allotment status by filling in details like PAN, Application number or DP client ID.
• Step 4: Press the Submit button
• Step 5: The allotment status will be shown in the window.

• Step 1: Open the link to the official registrar of the issue, MUFG Intime India Pvt.Ltd.
• Step 2: Select the company from the dropdown menu.
• Step 3: You check your allotment status by filling in details like PAN, application number or DP client ID.
• Step 4: Press the Submit button.
• Step 5: Your allotment status will be shown in the window.

• Step 1: Open the website of NSE.
• Step 2: Select the company name by selecting Equity & SME IPO bid details.
• Step 3: Fill in the necessary details like IPO Application number or PAN details after selecting the company symbol.
• Step 4: Press the 'Submit' button.
• Step 5: The allotment status will be shown in the window.

• Step 1: Open the website of Bombay Stock Exchange (BSE).
• Step 2: Click on 'Investors' option.
• Step 3: On the 'Investor Services' dropdown, click on 'Status of Issue Application'.
• Step 4: Click on 'Application Status Check'.
• Step 5: Select Equity in the issue type.
• Step 6: Fill in the required details including the 'Issue Name'.
• Step 7: Enter PAN number and click on 'Search' to view the status.

Luxury Time will debut on the BSE SME on December 11, the same day as Western Overseas Study Abroad, whose fixed-price IPO was subscribed 1.38 times. Both companies will finalise IPO share allotment by December 9, wrapping up one of the more crowded SME IPO weeks in the market.

GYR Capital Advisors acted as the merchant banker for the Luxury Time IPO. The company’s shares are set to list on the BSE SME platform on December 11, with IPO share allotment scheduled to be finalised on December 9, alongside Western Overseas Study Abroad.

Luxury Time, incorporated in 2008 and headquartered in New Delhi, is the exclusive authorised distributor in India for Swiss luxury brands TAG Heuer, Zenith, Bomberg and Exaequo. The company operates over 70 points of sale across India, along with two service stores in Mumbai and Delhi.

From the IPO proceeds, Luxury Time plans to deploy Rs 2.8 crore to set up four new retail stores, earmark Rs 9 crore towards working capital, and use the remaining funds for general corporate purposes, as per the RHP.

Luxury Time tapped the market to raise up to Rs 18.73 crore via IPO at the upper end of the Rs 78–82 per share price band. The offer comprised a fresh issue of 18.28 lakh shares and an offer-for-sale of 4.56 lakh shares by promoters.

Retail investors led the frenzy in the Luxury Time IPO, subscribing their portion a massive 860.5 times. The non-institutional investor (NII) quota was subscribed 402.47 times, while the QIB portion saw 205.58 times subscription, underscoring strong demand across all investor categories.

The Luxury Time IPO received a blockbuster response, with the Rs 68-crore valued Swiss luxury watch distributor’s issue subscribed 553.93 times during December 4–8. Investors bid for 92.35 crore shares against just 16.67 lakh shares on offer, via 2.19 lakh applications, translating into bids worth around Rs 7,573 crore.

Corona Remedies, headquartered in Ahmedabad, is a pharma formulation player with 67 brands across women’s healthcare, cardio-diabetes, pain management, urology and other therapeutic areas as of December 2024.

Before opening to the public, Corona Remedies raised Rs 195 crore from anchor investors on Friday. The company counts private equity firm ChrysCapital among its key backers.

The Rs 655.37 crore is entirely an offer for sale (OFS) by promoters and existing investors, including Sepia Investments, Anchor Partners and Sage Investment Trust. The company will not receive any fresh proceeds from the issue.

Retail investors drove early interest in the Corona Remedies IPO, with the RII quota subscribed 87% on Day 1. The Non-Institutional Investors (NII) portion was subscribed 79%, while the QIB category is yet to see any bids.

The Corona Remedies IPO was subscribed 62% on Day 1, with investors bidding for 28,17,234 shares against 45,71,882 shares on offer, NSE data showed. The three-day share sale will close on December 10.

SBI Securities notes that Meesho follows a technology-first playbook, integrating GenAI tools into its engineering stack to streamline code generation, speed up development and shorten deployment cycles. A simple, India-focused app design has helped Meesho scale efficiently, cut costs and enhance platform productivity.

Non-institutional investors bid for 291 crore shares versus just 7.32 crore shares reserved, while retail investors placed orders for 97.14 crore shares against 4.88 crore shares on offer. The broad-based response underscores Meesho’s strong appeal among both HNIs and retail investors.

Institutional demand for Meesho was particularly strong. The QIB portion saw bids for 1,807 crore shares against a reserved quota of 14.65 crore shares, highlighting high institutional conviction in Meesho’s business model and growth prospects.

The Rs 5,421 crore Meesho IPO, open from December 3 to 5, drew a massive 82 times overall subscription, one of the highest for a mainboard issue in recent times. Investors bid for 2,196 crore shares against just 26.86 crore shares on offer, reflecting strong demand across segments.

Meesho operates on a zero-commission marketplace model, earning most of its revenue from logistics services and advertising, not seller commissions. Despite posting net losses even after adjusting for exceptional items, the company has generated positive free cash flows for the last two years, signalling improving unit economics.

Meesho IPO allotment comes against the backdrop of a hyper-competitive market. The company is up against large e-commerce players like Amazon and Flipkart as well as traditional brick-and-mortar retailers. Any failure to defend market share or customer stickiness could weigh on Meesho’s growth and profitability over time.

The Wakefit IPO comes from one of India’s leading D2C home and furnishing brands, with a business built on an omnichannel model. Its presence spans its own website, exclusive COCO outlets, MBOs, online marketplaces and OTT-driven discovery, helping it build strong brand recall.

Despite strong early retail interest in the Wakefit IPO, the grey market is turning cautious. The sharp fall in GMP indicates traders are now pricing in tighter listing gains and possible concerns over fundamentals and sector competition.

The Wakefit IPO GMP has slumped to Rs 5, implying an estimated listing price of around Rs 200 per share, just 2.56% above the upper price band of Rs 195. This marks a sharp fall from nearly 18% GMP on December 7, signalling a sudden cooling in grey market enthusiasm.

The Wakefit IPO opened with moderate demand, with overall subscription at 0.13 times as of December 8, 2:54 PM. Retail investors led the pack with 0.63 times subscription, while NII bids stood at 0.5 times and the QIB portion was yet to see any participation.

Meesho’s IPO share allotment is likely to be finalised later tonight, December 8, after the issue saw a robust 79x subscription in the primary market.

In the grey market, Meesho shares are commanding a premium of around 38–42%, according to tracking platforms. Investorgain pegs the GMP at Rs 42, implying a potential listing gain of about 37.8%, while IPO Watch is quoting an even higher premium of around 42%.

Meesho shares are scheduled to list on both the NSE and BSE on December 10.

The IPO of Corona Remedies opened for subscription today, kicking off the first day of bidding for the Rs 655.37 crore issue. Investors can place bids till December 10 as the pharma company looks to offload part of its existing stake to the public.

The IPO is entirely an offer for sale (OFS), with promoters and existing shareholders selling 0.62 crore shares and no fresh capital being raised. Ahead of the issue, Corona Remedies mobilised Rs 194.85 crore from 15 anchor investors, including SBI Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mahindra AMC and Axis Mutual Fund.

TIMF Holdings, backed by US-based Think Investments, bought 7.69 lakh shares (0.83%) worth Rs 35.37 crore, becoming the largest buyer in the pre-IPO deal.

Axis Max Life Insurance and Malabar India Fund picked up 4.3 lakh shares each, investing around Rs 20 crore apiece.

Nephrocare clarified that the shares sold in the pre-IPO round will not be part of the IPO offer-for-sale.

Promoters including Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings and Investcorp sold a combined 2.44% stake worth Rs 104.18 crore in Nephrocare Health Services ahead of its IPO opening. The public issue of Nephroplus will open for subscription on December 10 and close on December 12. The anchor book will be conducted on December 9.

"Aequs operates in India's aerospace precision manufacturing sector with strong structural advantages. The company commands leading position in vertically integrated aerospace component manufacturing within a single SEZ, serving tier 1 global OEMs like Airbus, Boeing, and Safran. Its aerospace segment delivers consistent operational profitability with 19.4% EBITDA margins in FY25, operating in a high demand industry with multi decade aircraft order backlogs," said Abhinav Tiwari from Bonanza.

The analyst noted that the IPO proceeds will eliminate Rs 433 crore of debt, significantly reducing interest burden and enabling near term PAT profitability, which is a critical transformation for long term investors.

"For long-term investors, Aequs offers tangible visibility to profitability within 12-24 months and cash generation capability, while Meesho requires years to demonstrate sustainable unit economics and positive returns on capital invested, making it a higher risk venture with unproven near term value creation," he added.

Angel One kept a 'Subscribe for long term' rating for Meesho's IPO. "At the upper price band of Rs 111 per share, Meesho is valued at roughly Rs 50,096 cr post-issue; the company remains loss-making, so P/E is negative and not a meaningful valuation metric. On operating metrics the IPO price implies an FY25 price-to-sales of ~5.3x, underpinned by a robust GMV run-rate of $6.2 billion and improving marketplace contribution margins (3.8% of NMVinH1FY26)," the domestic brokerage said.

"While strong scale momentum supports the growth narrative, near-term profitability remains volatile, positioning the offering as suitable primarily for long-term investors with a high risk appetite," it added.

Ravi Singh, Chief Research Officer from Master Capital Services, however, highlighted that Meesho enters its IPO with strong cash-flow discipline and steady growth, driven by deep value-market penetration and efficient operations. "Meesho's growth is different because it is still tapping into a part of India that is not fully penetrated by large e-commerce players. A big chunk of its demand comes from first-time online buyers in smaller towns who are more focused on price and selection than on brand names," he said.

Profitability is possible, but it will likely come gradually rather than through any sudden turnaround, Singh said, adding that investors should look at this IPO as a "long-term execution story, not a quick-margin business".

Meesho operates in the highly competitive Indian e-commerce sector with weaker fundamentals, said Abhinav Tiwari, Research Analyst at Bonanza. “Despite achieving 1.8 billion annual transactions and 5.3x FY25 PS valuation, Meesho reported adjusted EBITDA losses of Rs. 5,518 crore in H1 FY26. While the company achieved positive free cash flows recently, the path to sustainable profitability remains uncertain, with H1FY26 showing deteriorating contribution margins at 3.8% versus 5.6% in FY24. The company faces intense competition from established players Amazon and Flipkart while still burning capital on marketing and technology investments,” he said.

Ahead of listing, the unlisted shares of the company were trading with nearly 29 percent grey market premium (GMP) over the IPO price, according to data on Investorgain.

According to IPO Watch, the unlisted shares of the company were trading with 32.25 percent GMP over the issue price.

Ahead of listing, the unlisted shares of the company were trading with nearly 38 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has fallen from the 44.59 percent quoted by the site on December 4 (Day 2 of public bidding).

According to IPO Watch, the unlisted shares of the company were trading with 42.34 percent GMP over the issue price.

• Step 1: Open the direct link to the registrar on this URL (https://ipostatus.kfintech.com/).
• Step 2: Select the IPO from the dropdown menu.
• Step 3: Investors can check the allotment status by filling in details like PAN, Application number or DP client ID.
• Step 4: Press the Submit button
• Step 5: The allotment status will be shown in the window

• Step 1: Open the direct link to the registrar on this URL (https://ipostatus.kfintech.com/).
• Step 2: Select the IPO from the dropdown menu.
• Step 3: Investors can check the allotment status by filling in details like PAN, Application number or DP client ID.
• Step 4: Press the Submit button
• Step 5: The allotment status will be shown in the window

• Step 1: Open the link to the official registrar of the issue on this URL.
• Step 2: Select the company from the dropdown menu.
• Step 3: You check your allotment status by filling in details like PAN, application number or DP client ID.
• Step 4: Press the Submit button.
• Step 5: Your allotment status will be shown in the window.

Ahead of listing, the unlisted shares of the company were trading with nearly 8 percent grey market premium (GMP) over the IPO price, according to data on Investorgain. The GMP has fallen from the 10.58 percent quoted by the site on December 4 (Day 2 of public bidding), but increased from the 5.77 percent quoted on the day the IPO closed for subscription (December 5).

According to IPO Watch, the unlisted shares of the company were trading with 7.69 percent GMP over the issue price.

• Step 1: Open the website of NSE by clicking on this direct link.
• Step 2: Select the company name by selecting Equity & SME IPO bid details.
• Step 3: Fill in the necessary details like IPO Application number or PAN details after selecting the company symbol.
• Step 4: Press the 'Submit' button.
• Step 5: The allotment status will be shown in the window.

• Step 1: Open the website of Bombay Stock Exchange (BSE).
• Step 2: Click on 'Investors' option.
• Step 3: On the 'Investor Services' dropdown, click on 'Status of Issue Application'.
• Step 4: Click on 'Application Status Check'.
• Step 5: Select Equity in the issue type.
• Step 6: Fill in the required details including the 'Issue Name'.
• Step 7: Enter PAN number and click on 'Search' to view the status.

Applicants can check their allotment status online on the official websites of BSE and NSE, as well as the official website of the registrar of the respective IPO.

The allotment statuses of three mainboard IPOs will likely be finalized today. These include Meesho IPO, Vidya Wires IPO and Aequs IPO. Follow our LIVE blog for all the latest updates about IPOs.